Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) had Income from Continuous Operations of $-1.74M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.74M |
|
-- |
|
-- |
|
$1.84M |
|
$-1.84M |
|
$0.10M |
|
$-1.74M |
|
$-1.74M |
|
$-1.74M |
|
|
Income from Continuous Operations |
$-1.74M |
$-1.74M |
|
$-1.74M |
|
$-1.84M |
|
$-1.84M |
|
24.72M |
|
24.72M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$11.93M |
|
$0.19M |
|
$0.44M |
|
$12.37M |
|
$1.14M |
|
-- |
|
-- |
|
$1.14M |
|
$11.23M |
|
$11.23M |
|
$11.23M |
|
24.62M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.51% |
|
-15.51% |
|
-14.08% |
|
-15.51% |
|
$0.46 |
|
-- |
|
-- |
|